Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 02, 2026 09:00 ET | Source: Oncolytics Biotech, Inc.

Oncolytics Biotech® Announces Appointment of Steve Glover to Board of Directors and Promotion of John McAdory to Chief Operating Officer

Oncolytics Biotech announced the appointment of Steve Glover to its Board of Directors and the promotion of John McAdory to Chief Operating Officer.
June 01, 2026 09:00 ET | Source: Oncolytics Biotech, Inc.

Oncolytics Biotech® Announces Positive Initial Preclinical Findings Supporting Further Evaluation of Pelareorep in Combination with RAS-Targeted Approaches

Oncolytics announced data demonstrating evidence of greater anti-tumor activity with pelareorep in combination with RAS inhibitor modalities.
June 01, 2026 08:00 ET | Source: Lyell Immunopharma, Inc

Lyell Immunopharma Announces Participation in Goldman Sachs 47th Annual Global Healthcare Conference 2026

SOUTH SAN FRANCISCO, Calif., June 01, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen...
May 15, 2026 09:49 ET | Source: BCC Research LLC

AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment

How chronic disease prevalence, infectious disease testing, AI investment, personalized medicine and regulatory change are shaping the diagnostics industry
May 14, 2026 07:45 ET | Source: Research and Markets

C-Met-Targeted Immunotherapies Pipeline Competitive Intelligence Report 2026: CCR8-targeted R&D Programs and Profile of CCR8-targeted Immunotherapies by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of c-Met-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
May 13, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Global Colorectal Cancer Diagnostics and Therapeutics Market Anticipates Impressive Growth Trajectory at a CAGR of ~9% by 2034 | DelveInsight

New York, USA, May 13, 2026 (GLOBE NEWSWIRE) -- Global Colorectal Cancer Diagnostics and Therapeutics Market Anticipates Impressive Growth Trajectory at a CAGR of ~9% by 2034 | DelveInsight The...
May 08, 2026 09:07 ET | Source: Research and Markets

AI in Oncology Research Report 2026 - Global Market Forecast to 2036: Intensifying Focus on Precision Medicine and the Rapid Expansion of Intelligent Diagnostic Frameworks

Dublin, May 08, 2026 (GLOBE NEWSWIRE) -- The "AI in Oncology Market by Component, Cancer Type, and Application - Global Forecast to 2036" has been added to ResearchAndMarkets.com's offering.Global...
May 06, 2026 16:05 ET | Source: Lyell Immunopharma, Inc

Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026

PiNACLE pivotal clinical trial evaluating ronde-cel in patients with LBCL in third- or later-line setting on track to report additional data in second half of 2026, with pivotal data expected mid-2027...
May 04, 2026 09:00 ET | Source: Oncolytics Biotech, Inc.

Oncolytics Biotech® Reports Durable Responses in Second-Line RAS-Mutant MSS Colorectal Cancer

Oncolytics announced new data in metastatic colorectal cancer, demonstrating 3-4x improvement in duration response vs. historical 4-6 month benchmark.
April 22, 2026 07:24 ET | Source: Research and Markets

Pharmaceuticals and Biotechnology Oncology Collaboration and Licensing Agreements Analysis Report 2026 with Directory of 2,900+ Deals Signed Since 2016

Dublin, April 22, 2026 (GLOBE NEWSWIRE) -- The "Oncology Collaboration and Licensing Deals 2021-2026" report has been added to ResearchAndMarkets.com's offering.This report offers the most...